Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. test sars cov 2 antigen test
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Test Sars Cov 2 Antigen Test Articles & Analysis

31 news found

The Role of Laser Therapy and Advanced Diagnostics in Modern Clinical Medicine

The Role of Laser Therapy and Advanced Diagnostics in Modern Clinical Medicine

Laser therapy is transforming clinical medicine, offering innovative solutions for skin therapy, cervical surgery, and gynecological procedures. Advanced equipment, such as specialized gynecology tables and rotary vane medical vacuum pumps, enhances precision and patient comfort in surgical settings. In diagnostics, the use of antigen rapid test kits and in vitro diagnostic hematology is ...

ByContent Management Test Company 89798798


Groundbreaking Possibility for Alertgy`s Non-Invasive Propriety Sensor for Detecting Covid-19

Groundbreaking Possibility for Alertgy`s Non-Invasive Propriety Sensor for Detecting Covid-19

The first phase of the project will explore the possibility that the dielectric-based technology can be tuned to detect inactivated, non-infectious SARS-CoV-2. The second phase will demonstrate that the transformative dielectric-based device can detect SARS-CoV-2 with specificity and can ...

ByAlertgy


NanoPin Technologies Founder`s Study Demonstrates Greater Accuracy in Detecting TB in Infants

NanoPin Technologies Founder`s Study Demonstrates Greater Accuracy in Detecting TB in Infants

NanoPin Technologies Inc, a biotechnology company focused on developing advanced diagnostics to improve the lives of millions of individuals affected by infectious diseases worldwide, announced the release of a scientific study conducted by founder Tony Hu, Ph.D. Dr. Hu is a professor and Weatherhead Presidential Chair in Biotechnology Innovation at the Tulane University School of Medicine. ...

ByNanoPin Technologies Inc.


Kephera Diagnostics receives $417,074 grant award from the Massachusetts Life Sciences Center to accelerate development of its rapid COVID-19 Antigen Test

Kephera Diagnostics receives $417,074 grant award from the Massachusetts Life Sciences Center to accelerate development of its rapid COVID-19 Antigen Test

Today, the Baker-Polito Administration announced that more than $1.5 million has been awarded to four projects that seek to increase testing capacity and provide solutions for coronavirus testing. The funding is through the Accelerating Coronavirus Testing Solutions (A.C.T.S.) Program, designed and administered by the Massachusetts Life Sciences Center, which supports projects focused on two core ...

ByKephera Diagnostics, LLC


Congratulations! Reetoo COVID-19 Ag Self-Test kit obtained CE certification

Congratulations! Reetoo COVID-19 Ag Self-Test kit obtained CE certification

Recently, Reetoo SARS-CoV-2 Antigen Rapid Self-test Kit (Colloidal Gold) received CE certification accredited by CeCert Sp. z o.o. and completed clinical validation in Vitalabo Laboratoria Medyczne Sp. z o.o. according to the latest EU guidance MDCG 2021-21 Guidance on performance evaluation of ...

ByShenzhen Reetoo Biotechnology Co.,Ltd


Breaking News! Reetoo Monkeypox Virus Real Time PCR Kit

Breaking News! Reetoo Monkeypox Virus Real Time PCR Kit

Suggested by WHO, detection of viral DNA by polymerase chain reaction (PCR) is the preferred laboratory test for monkeypox. In order to assist in the rapid detection of monkeypox virus and timely find monkeypox infection cases, Reetoo biotech has urgently developed Monkeypox Virus Real Time PCR Kit (fluorescence PCR). ...

ByShenzhen Reetoo Biotechnology Co.,Ltd


Creative Diagnostics Announces Antigens for Epstein-Barr Virus Antibody Tests

Creative Diagnostics Announces Antigens for Epstein-Barr Virus Antibody Tests

As a global leading supplier of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics recently launches recombinant antigens p18 and p23 (viral capsid antigens, VCA), p54 and p138 (early antigens, EA) and EBNA1 (nuclear antigen, EBNA). These recombinant antigens in immunoassays are suitable for the detection of IgG and IgM antibodies against EBV in blood ...

ByCreative Diagnostics


miDiagnostics launches its CE-IVD certified ultra-fast COVID-19 PCR Test

miDiagnostics launches its CE-IVD certified ultra-fast COVID-19 PCR Test

A total of 766 study subjects were tested for SARS-CoV-2 with both miDiagnostics’ Test and a traditional RT-PCR used in a centralized setting. Over 300 of these subjects were found to be SARS-CoV-2 positive, representing a broad range of viral loads ...

BymiDIAGNOSTICS


Covid-19 or Seasonal Allergy: How to differentiate?

Covid-19 or Seasonal Allergy: How to differentiate?

COVID-19 and seasonal allergies have many of the same signs and symptoms. However, there are some differences, knowing them can help you seek out the right treatments to provide effective relief. Unlike COVID-19, seasonal allergies aren't caused by a virus. Seasonal allergies are immune system responses triggered by exposure to allergens, such as seasonal tree or grass pollens. To complicate ...

ByHYCOR Biomedical


Quidel Announces Preliminary Revenue for Fourth Quarter 2021

Quidel Announces Preliminary Revenue for Fourth Quarter 2021

Quidel Corporation (NASDAQ: QDEL) (“Quidel”),a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it expects total revenues in the fourth quarter of 2021 to be in the range of $633 million to $637 million and full year total revenues to be in the range of $1,695 million to $1,699 million. COVID-19 ...

ByQuidel Corporation


Quidel’s Antigen Tests Detect the Omicron Variant

Quidel’s Antigen Tests Detect the Omicron Variant

Bryant said: “At Quidel, we continuously monitor the evolution and activity of COVID-19 variants in circulation, and the Omicron variant is no exception. Recent testing using live South African samples confirmed that our QuickVue® At-Home OTC COVID-19 Test and our Sofia® SARS Antigen FIA are detecting the ...

ByQuidel Corporation


Takeover of terraplasma medical GmbH by the Viromed Group

Takeover of terraplasma medical GmbH by the Viromed Group

The majority takeover of terraplasma medical GmbH by Viromed Plasma GmbH, a member of the Viromed Group, was announced today. terraplasma GmbH will continue to hold shares in terraplasma medical GmbH in order to contribute its expertise in the field of cold atmospheric plasmas in the future. The common goal of Viromed and terraplasma is to establish terraplasma medical as the world's leading ...

Byterraplasma medical GmbH


EIB backs Belgian rapid COVID-19 PCR Test developer miDiagnostics

EIB backs Belgian rapid COVID-19 PCR Test developer miDiagnostics

In the context of the ongoing coronavirus crisis, miDiagnostics adapted its R&D and product development plans towards the development of a rapid PCR test for SARS-CoV-2, aimed at providing PCR accuracy whilst being just as fast as rapid antigen tests. Tests in the field, ...

BymiDIAGNOSTICS


New Rapid Molecular COVID-19 Test from Anavasi Diagnostics Awarded $14.9 Million by NIH to Accelerate Test Availability

New Rapid Molecular COVID-19 Test from Anavasi Diagnostics Awarded $14.9 Million by NIH to Accelerate Test Availability

The funding will accelerate the launch and broad market availability of the AscencioDx™ molecular diagnostic platform for the detection of RNA indicative of the SARS-CoV-2 / COVID-19 virus. Currently in clinical trials in the U.S., Anavasi expects to file its submission to the U.S. ...

ByAnavasi Diagnostics


CEO Nick Traggis is working to scale manufacturing as the healthcare market demands faster point-of-care diagnostics.

CEO Nick Traggis is working to scale manufacturing as the healthcare market demands faster point-of-care diagnostics.

Traggis started working with LightDeck Diagnostics founder Chris Myatt at a previous endeavor, Precision Photonics, a Boulder-based manufacturer of laser optics, in the early 2000s. Originally named MBio Diagnostics, LightDeck began as a “skunkworks effort” inside Precision. “I ended up taking over the reins there at Precision Photonics around the time Chris started focusing ...

ByLightDeck Diagnostics


Lumos Diagnostics Receives Authorization for CoviDx™ SARS-CoV-2 Rapid Antigen Test in Canada

Lumos Diagnostics Receives Authorization for CoviDx™ SARS-CoV-2 Rapid Antigen Test in Canada

Lumos Diagnostics (ASX: LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced that Health Canada has granted Interim Order authorization for the Lumos CoviDx™ SARS-CoV-2 Rapid Antigen Test. The CoviDx test gives qualified healthcare providers qualitative, ...

ByLumos Diagnostics


Box Hill Hospital Emergency Department Initiates Trial Using FebriDx

Box Hill Hospital Emergency Department Initiates Trial Using FebriDx

Lumos Diagnostics (ASX: LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced that the Emergency Department at Box Hill Hospital in Melbourne, Australia, has initiated a 300-subject investigator-led trial using Lumos’ FebriDx® POC test to rapidly identify patients presenting with a suspected viral infection consistent with COVID-19. This study is based on ...

ByLumos Diagnostics


miDiagnostics is pilot testing its ultra-fast PCR COVID-19 Test at Brussels Airport

miDiagnostics is pilot testing its ultra-fast PCR COVID-19 Test at Brussels Airport

miDiagnostics, which originated from an innovative co-operation between imec and Johns Hopkins University, is taking another important step in its goal to enabling fast and high-quality diagnostic testing at any location. Today, the company announced that, in close cooperation with Brussels Airport, Ecolog and Eurofins, it is setting up a pilot program to test passengers with the aim of ...

BymiDIAGNOSTICS


Why we Started (TBT): HIV Testing

Why we Started (TBT): HIV Testing

Why HIV Testing is Important HIV Testing is critical to reducing its spread. The CDC recommends that all people ages 13-64 get tested at least once, and individuals deemed high risk should be tested more frequently. A positive test allows individuals to then seek treatment (there are several forms of effective treatment currently available) and prevent transmission to others. How HIV Testing ...

ByFluxergy


SARS-Cov-2 Antigen Rapid Test Kits

SARS-Cov-2 Antigen Rapid Test Kits

CARDIMED B.V. is the official distributor for the SARS-Cov-2 Antigen Rapid Test Kits (Lepu Medical) in the Netherlands. The advantages at a glance: Non-invasive Easy to use Convenient, no equipment required Fast, get a result in 15 minutes Stable, with high accuracy Cost-effective, cost-efficient The ...

ByCARDIMED B.V.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT